Skip to content
Search

Latest Stories

DHSC updates June 2023 price concessions after CPE members report medicine pricing issues

Department of Health and Social Care (DHSC) has updated the final price concessions for June 2023, following a discussion by Community Pharmacy England regarding medicine pricing issues reported by pharmacy owners (its members).

A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.


Community Pharmacy England encouraged pharmacies to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on the Community Pharmacy England website along with full details of the supplier and price paid for any products sourced above the Drug Tariff price.

The association will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.

“Since this announcement, we have sent a strong and clear message back to Government that pharmacies cannot continue to subsidise the NHS medicines bill. Following the review of the concessionary price process, a package of measures has been developed to improve the system,” said CPE.

One of the solutions agreed between CPE and DHSC is that from 1st April 2023, all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession.

Furthermore, from May 2023, DHSC has implemented a process to roll over prices to the following month for any concessions requested after the 23rd of the month provided these prices were agreed with us.

CPE is also continuing to work with DHSC on how a ‘retrospective increased payment’ my apply, when appropriate.

Full list below:

DrugPack sizePrice concession
* Alginate raft-forming oral suspension sugar free500£3.80
Amiloride 5mg tablets28£13.46
Amoxicillin 125mg/5ml oral suspension sugar free100£2.68
Benzoyl peroxide 5% / Clindamycin 1% gel60£22.22
Buprenorphine 8mg sublingual tablets sugar free7£11.36
Calamine lotion200£1.86
Chloramphenicol 0.5% eye drops10£12.51
Chlorphenamine 2mg/5ml oral solution sugar free150£4.01
Clotrimazole 500mg pessary and Clotrimazole 2% cream1£10.79
Co-careldopa 12.5mg/50mg tablets90£4.93
Co-trimoxazole 80mg/400mg tablets28£2.34
Docusate 50mg/5ml oral solution sugar free300£18.81
Flucloxacillin 250mg capsules28£2.45
Isoniazid 100mg tablets28£60.00
Ivabradine 5mg tablets56£28.33
Letrozole 2.5mg tablets14£6.66
Methylphenidate 5mg tablets30£3.45
Mometasone 0.1% cream30£3.60
Mycophenolate mofetil 500mg tablets50£7.69
Pantoprazole 20mg gastro-resistant tablets28£6.62
Pantoprazole 40mg gastro-resistant tablets28£9.23
Paracetamol 500mg effervescent tablets100£10.34
Pregabalin 300mg capsules56£4.02
Promethazine hydrochloride 25mg tablets56£29.32
Quinine sulfate 200mg tablets28£7.97
Risperidone 500microgram tablets20£2.98
Rosuvastatin 20mg tablets28£4.98
Sodium chloride 0.9% nebuliser liquid 2.5ml unit dose ampoules20£11.04
Tacrolimus 0.1% ointment60£41.69
Tacrolimus 0.1% ointment30£22.36
Tamsulosin 400microgram / Dutasteride 500microgram capsules30£14.53
Tolterodine 2mg tablets56£3.55
Topiramate 100mg tablets60£16.53
Tramadol 37.5mg / Paracetamol 325mg tablets60£7.38
Trazodone 50mg capsules84£3.45
Venlafaxine 75mg tablets56£11.51
Zolmitriptan 2.5mg tablets6£18.85
Zolmitriptan 2.5mg tablets12£37.70

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less